CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Operating activities:
Net income (loss)	$ 352,000	$ (267,000)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation	0	1,000
Fair value of warrants	105,000	0
Gain on patent assignment	(880,000)	0
Effect of changes in:
Inventory	(11,000)	0
Operating lease right of use asset	36,000	35,000
Accounts payable and accrued expenses	55,000	92,000
Advances from distributor, net	0	164,000
Operating lease liability	(40,000)	(36,000)
Prepaid expenses	7,000	0
Net cash used in operating activities	(376,000)	(11,000)
Investing activities:
Proceeds from patent assignment	880,000	0
Net cash provided by investing activities	880,000	0
Financing activities:
Repayment of note payable	(2,000)	0
Net cash used in financing activities	(2,000)	0
Net increase (decrease) in cash and cash equivalents	502,000	(11,000)
Cash and cash equivalents, beginning of period	179,000	18,000
Cash and cash equivalents, end of period	681,000	7,000
Supplemental disclosures of cash flow information:
Cash paid for interest	1,000	4,000
Cash paid for income taxes	$ 0	$ 0